セッション

Distinct roles of AKT3 in regulation of proliferation and metastasis of prostate cancer

[演者] Chih-Pin Chuu:1
[著者] Chieh Huo:1, Hui Ping Lin:1, Ching Yu Lin:1
1:National Health Research Institutes, Taiwan・Institute of Cellular and System Medicine

Higher serum testosterone predicts favorable prognosis in Enzalutamide and Abiraterone treated castration resistant prostate cancer patients

[演者] Shinichi Sakamoto:1
[著者] Shuhei Kamada:2, Hiroki Kitou:6, Yasutaka Yamada:3, Kousuke Higuchi:4, Nobuyoshi Takeuchi:1, Koji Kawamura:1, Takashi Imamoto:1, Akira Komiya:1, Hiroaki Matsumoto:8, Hideyasu Matsuyama:8, [8] Toyofusa Tobe:5, Hiroyoshi Suzuki:7, Koichiro Akakura:6, Tomohiko Ichikawa:1
1:Urology, Chiba University Faculty of Medicine, 2:Urology, Yokohama Rosai Hospital, 3:Urology, Asahi Hospital, 4:Urology, Funabashi Municipal Medical Center, 5:Urology, Saiseikai Utsunomiya Hospital, 6:Urology, Japan Community Healthcare Organization Tokyo Shinjuku Medical Center, 7:Urology, Sakura medical Center, Toho University, 8:Urology, Yamaguchi University Graduate School of Medicine

Serum testosterone recovery levels after cessation of androgen deprivation therpay in prostate cancer patients with radiation therapy

[演者] Akinori Takei:1
[著者] Shinichi Sakamoto:1, Yuki Kaneko:1, Shinpei Saito:1, Takaaki Tamura:1, Miki Fuse:1, Koji Kawamura:1, Takashi Imamoto:1, Akira Komiya:1, Hiroyoshi Suzuki:2, Takeshi Ueda:4, [4] Koichiro Akakura:3, Tomohiko Ichikawa:1
1:Urology, Chiba University Graduate School of Medicine and School of Medicine, 2:Urology, Sakura medical Center, Toho University, 3:Urology, Japan Community Healthcare Organization Tokyo Shinjuku Medical Center, 4:Urology, Chiba Cancer Center

Bicalutamide 150mg as first-line monotherapy of patients with low and intermediate risk prostatic cancer

[演者] Wilmosh Mermershtain:1
[著者] Irina Lazarev:1, Irina Gusakova:1, Samuel Ariad:1, Keren Rouvinov:1
1:Soroka University Medical Center, Beer Sheva, Israel・Department of Oncology・Onco-Urology

詳細検索
アプリバナー iPhone版,iPad版 Android版